A detailed history of Wellington Management Group LLP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Wellington Management Group LLP holds 2,612,856 shares of ASND stock, worth $331 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,612,856
Previous 2,745,872 4.84%
Holding current value
$331 Million
Previous $415 Million 14.15%
% of portfolio
0.06%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$121.07 - $153.67 $16.1 Million - $20.4 Million
-133,016 Reduced 4.84%
2,612,856 $356 Million
Q1 2024

May 15, 2024

BUY
$123.45 - $159.4 $339 Million - $438 Million
2,745,872 New
2,745,872 $415 Million
Q4 2023

Feb 12, 2024

BUY
$86.1 - $127.36 $280 Million - $414 Million
3,248,293 New
3,248,293 $409 Million
Q3 2023

Nov 14, 2023

BUY
$86.5 - $103.97 $11.1 Million - $13.3 Million
128,272 Added 4.07%
3,277,172 $307 Million
Q2 2023

Aug 14, 2023

BUY
$69.96 - $97.84 $15 Million - $21 Million
215,108 Added 7.33%
3,148,900 $281 Million
Q1 2023

May 12, 2023

SELL
$104.9 - $126.78 $12.6 Million - $15.2 Million
-119,813 Reduced 3.92%
2,933,792 $315 Million
Q4 2022

Feb 13, 2023

SELL
$99.42 - $131.97 $61.5 Million - $81.6 Million
-618,621 Reduced 16.85%
3,053,605 $373 Million
Q3 2022

Nov 14, 2022

BUY
$84.03 - $110.23 $10.3 Million - $13.6 Million
123,089 Added 3.47%
3,672,226 $379 Million
Q2 2022

Aug 15, 2022

SELL
$78.08 - $117.61 $87.2 Million - $131 Million
-1,116,442 Reduced 23.93%
3,549,137 $330 Million
Q1 2022

May 16, 2022

BUY
$102.18 - $135.75 $60.8 Million - $80.8 Million
594,855 Added 14.61%
4,665,579 $548 Million
Q4 2021

Feb 11, 2022

BUY
$127.1 - $169.66 $15.9 Million - $21.3 Million
125,480 Added 3.18%
4,070,724 $548 Million
Q3 2021

Nov 15, 2021

BUY
$112.67 - $176.92 $57.6 Million - $90.4 Million
510,971 Added 14.88%
3,945,244 $629 Million
Q2 2021

Aug 16, 2021

SELL
$121.62 - $145.29 $7.06 Million - $8.44 Million
-58,060 Reduced 1.66%
3,434,273 $452 Million
Q1 2021

May 17, 2021

BUY
$124.92 - $173.33 $11.3 Million - $15.7 Million
90,775 Added 2.67%
3,492,333 $450 Million
Q4 2020

Feb 12, 2021

BUY
$151.2 - $182.76 $22.6 Million - $27.4 Million
149,797 Added 4.61%
3,401,558 $567 Million
Q3 2020

Nov 16, 2020

BUY
$134.29 - $154.32 $197 Million - $226 Million
1,465,470 Added 82.04%
3,251,761 $502 Million
Q2 2020

Aug 14, 2020

BUY
$110.87 - $156.01 $12.9 Million - $18.1 Million
116,145 Added 6.95%
1,786,291 $264 Million
Q1 2020

May 14, 2020

SELL
$97.01 - $145.11 $4.58 Million - $6.85 Million
-47,189 Reduced 2.75%
1,670,146 $188 Million
Q4 2019

Feb 11, 2020

BUY
$91.45 - $139.12 $157 Million - $239 Million
1,717,335 New
1,717,335 $239 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.07B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.